Eventfree survival of maralixibattreated patients with Alagille syndrome compared to a realworld cohort from GALA

dc.article.end-page1292en
dc.article.start-page1279en
dc.citation.doi10.1097/HEP.0000000000000727en
dc.contributor.authorB E Hansenen
dc.contributor.authorS M Vandrielen
dc.contributor.authorP Vigen
dc.contributor.authorW Garneren
dc.contributor.authorE et alen
dc.contributor.authorChristina Hajinicolaouen
dc.contributor.authorMarisa Berettaen
dc.date.accessioned2025-01-20T17:21:03Z
dc.date.available2025-01-20T17:21:03Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationSCOPUSen
dc.identifier.urihttps://hdl.handle.net/10539/43553
dc.journal.titleEventfree survival of maralixibattreated patients with Alagille syndrome compared to a realworld cohort from GALAen
dc.journal.volume79en
dc.titleEventfree survival of maralixibattreated patients with Alagille syndrome compared to a realworld cohort from GALAen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
725.2 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client